2Department of Nursing, Eskişehir Osmangazi University Faculty of Health Science, Eskişehir-Türkiye DOI : 10.5505/tjo.2024.4202 OBJECTIVE
This study was conducted to evaluate the supportive care needs and coping attitudes of breast cancer patients according to their neuropathic pain status.
METHODS
This case-control study design was conducted with 212 patients who were being treated in the daily
chemotherapy unit of a hospital in İstanbul, who agreed to participate in the study and met the inclusion
criteria. The S-LANSS pain scale was used to determine the neuropathic pain status of the patients. A
Descriptive Information Form, Supportive Care Needs Scale, and Coping Attitudes Scale were used to
collect the data.
RESULTS
The study sample consisted of case group patients with neuropathic pain (n=100) and control group
patients without neuropathic pain (n=112). The mean age of the participants was 50 (45-54) in the case
group and 49 (45-57) in the control group. In the case group, 24.5% used paclitaxel chemotherapy, and
40.6% had no knowledge about neuropathic pain. In the control group, 21.7% used paclitaxel chemotherapy,
and 46.2% had no knowledge about neuropathic pain. There was no statistically significant
difference between the groups in terms of total scores and sub-dimensions of the Supportive Care Needs
Scale and total scores and sub-dimensions of the Coping Orientations to Problems Experienced scale.
CONCLUSION
Coping attitudes and supportive care needs of patients do not change according to the presence of neuropathic
pain. Nearly half of the patients receiving neurotoxic chemotherapy, which frequently causes
neuropathic pain, have no knowledge about neuropathic pain.